LivaNova’s VNS Therapy System Receives CE Mark for Difficult-to-Treat Depression

LivaNova Symmetry VNS Therapy System
Image: LivaNova
LivaNova, a leading medical technology and innovation company, based in London, announced its Vagus Nerve Stimulation Therapy® (VNS Therapy) System, Symmetry™, earned CE Mark approval for Difficult-to-Treat Depression (DTD). Two […]
To access this page, watch the live streams and videos on-demand, please register free of charge to the WT | Wearable Technologies COMMUNITY.
Previous articleZeto Raises $7.3M in Series A Funding for EEG Headset and Software Platform
Next articleProGlove Unveils MARK Display Wearable Scanner and ProGlove Cloud Analytics Solution
Cathy Russey () is Online Editor at WT | Wearable Technologies and specialized in writing about the latest medical wearables and enabling technologies on the market. Cathy can be contacted at info(at)wearable-technologies.com.